Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma
NCT00428688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27
Last updated 2023-04-12
Summary
The aim of the proposed study is to assess endothelial function and IMT, as correlates of cardiovascular disease (CVD), in young adult Hodgkin's disease (HD) survivors, and to relate endothelial function to other risk factors including obesity, dyslipidemia, hyperinsulinemia and fasting glucose.
Conditions
- Hodgkin's Lymphoma
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Dalit Modan, M.D · Sheba Medical Center
-
Michael Schechter, M.D · Sheba Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- Israel
Study Locations
More Related Trials
-
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
NCT05705531 ·Status: RECRUITING
-
Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
NCT06890091 ·Status: NOT_YET_RECRUITING
-
Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
NCT00165438 ·Status: COMPLETED
-
Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT02856646 ·Status: COMPLETED
-
Kinetic of Cytokines Decrease and Hodgkin Lymphoma Prognostic
NCT01833884 ·Status: COMPLETED ·Phase: NA
-
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma
NCT00141700 ·Status: TERMINATED ·Phase: PHASE2
-
Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma
NCT02242097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001301 ·Status: COMPLETED
-
Microenvironmental Trial of Classical Hodgkin Lymphoma in Adolescents
NCT06814860 ·Status: COMPLETED
-
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma
NCT00186394 ·Status: COMPLETED ·Phase: PHASE2
-
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
NCT01829958 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Free Chemotherapy for Early Hodgkin Lymphoma
NCT04866654 ·Status: RECRUITING ·Phase: PHASE2
-
Lean Body Mass and Side Effects in Patients With Lymphoma
NCT04698616 ·Status: UNKNOWN
-
Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma
NCT06761274 ·Status: RECRUITING ·Phase: NA
-
Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma
NCT00143871 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
NCT04621604 ·Status: TERMINATED ·Phase: NA
-
Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma
NCT00438880 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
NCT01649856 ·Status: COMPLETED ·Phase: PHASE3
-
Early Markers of Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated With Radiation Therapy
NCT02404818 ·Status: COMPLETED
-
Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade
NCT00551798 ·Status: COMPLETED ·Phase: NA
-
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
NCT04696705 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs
NCT05284396 ·Status: UNKNOWN
-
Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
NCT00400907 ·Status: UNKNOWN
-
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
NCT00934986 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
NCT06090539 ·Status: RECRUITING ·Phase: PHASE1/PHASE2